Seelos Therapeutics, Inc.

NASDAQ:SEEL

0.199 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Omzet 2.2030000.375005.7634.8399.2592.5118.4164.1014.9732.9745.9571.271.8672.3990.3590.1110.1480.06801.55.7090.056
Kosten van de omzet 0.0570.0530022.56300.1173.8910.9220.9182.6314.5542.2373.9430.1280000000.0270.045-0.2571.35.1860
Brutowinst 2.146-0.05300-22.1880-0.1171.8723.9178.341-0.123.8621.8641.032.8455.9571.271.8672.3990.3590.1110.1210.0230.2570.20.5230.056
Brutowinstmarge 0.974000-59.168000.3250.8090.901-0.0480.4590.4550.2070.9571111110.8170.338257,1500.1330.0921
Onderzoek- en ontwikkelingskosten 30.11758.6246.64910.98422.5631.223.4636.83114.64921.2885.1235.3755.8212.111.8835.4115.0235.42511.22210.6848.43921.61612.4566.8922.42.3022.079
Algemene en administratieve kosten 12.58512.29615.027.7757.5597.9287.218.43410.51611.41813.55415.37711.46310.1524.1965.7215.6345.5716.8786.985.9016.0654.773.2091.82.6351.825
Verkoop- en marketingkosten -0.05700000000000000000000000000
Verkoop-, algemene en administratieve kosten 12.52812.29615.027.7757.5597.9287.218.43410.51611.41813.55415.37711.46310.1524.1965.7215.6345.5716.8786.985.9016.0654.773.2091.82.6351.825
Overige kosten 0-3.0170.230-0.3750.0010.077-0.022-0.0640.082-0.3760.1752.7610.168457.023000000000.2570.100
Bedrijfskosten 42.64570.91661.66918.75929.7479.14810.67315.26525.16530.918.67720.75220.04422.4316.0811.13110.65710.99618.117.66414.3427.68117.22610.3594.34.9373.903
Bedrijfsresultaat -40.499-70.916-61.669-18.759-29.747-9.148-10.675-13.407-21.35-22.559-17.367-24.894-18.18-21.401-3.82-5.174-9.387-9.129-15.701-17.305-14.229-27.56-17.203-10.102-4.1-4.414-3.847
Bedrijfsresultaat ratio -18.384000-79.32500-2.326-4.412-2.436-6.916-2.958-4.433-4.304-1.285-0.868-7.389-4.89-6.544-48.153-128.488-186.182-252.66-10,101,747-2.733-0.773-68.486
Totaal overige inkomsten en kosten netto 2.617-2.618-4.379-0.342-21.133-0.07-0.9937.4433.070.0823.654-7.8290.4260.715-0.575-0.935-0.2060.627-0.2220.082-0.153-0.081-0.1750.1261.800
Inkomen voor belasting -37.882-73.534-66.048-19.101-50.88-9.218-11.749-7.433-19.023-22.477-15.87-25.044-18.117-29.508-32.48-6.109-9.593-8.611-15.924-17.563-17.466-27.884-17.378-9.976-2.300
Inkomen voor belasting ratio -17.196000-135.6800-1.29-3.931-2.428-6.32-2.976-4.418-5.934-10.923-1.025-7.551-4.612-6.637-48.871-157.715-188.371-255.227-9,976,002-1.53300
Belastingkosten -0.1112.6041.4850.119-0.497-0.07-11.9110.781-0.6911.0680.5160.37718.029-0.438-0.938-0.806-0.567-0.481-0.539-0.232-0.243-1.029-1.272-1.60.3650.01
Nettowinst -37.882-76.138-67.533-19.22-50.383-9.2420.321-7.433-19.023-21.786-16.938-31.771-18.117-29.508-32.043-5.171-8.787-8.043-15.442-17.024-17.234-27.642-16.175-8.83-2.5-4.779-3.857
Nettowinstmarge -17.196000-134.35500-1.29-3.931-2.353-6.746-3.775-4.418-5.934-10.775-0.868-6.917-4.308-6.437-47.371-155.62-186.732-237.555-8,830,071-1.667-0.837-68.669
WPA (Winst Per Aandeel) -7.73-21.48-22.29-12.88-74.43-89.9724.32-67.41-3,442.83-165-147.66-347.13-271.44-747.22-1,627.6-278.08-482.15-547.23-1,323.03-1,757.01-2,304.92-4,617.69-2,856.24-1,817.26-819.94-2,880.65-2,857.38
Verwaterde WPA -7.73-21.48-22.29-12.88-74.43-89.9724.32-67.41-3,442.83-165-147.66-347.13-271.44-747.22-1,627.6-278.08-482.15-547.23-1,323.03-1,757.01-2,304.92-4,617.69-2,856.24-1,817.26-819.94-2,880.65-2,857.38
EBITDA -40.442-73.759-61.326-18.714-29.33-9.106-10.479-13.587-21.012-22.559-19.096-16.512-17.564-11.205-2.821-4.616-8.356-8.586-14.433-16.391-12.826-26.413-16.502-9.97-5.8-4.073-3.816
EBITDA ratio -18.358000-78.21300-2.358-4.342-2.436-7.605-1.962-4.283-2.253-0.949-0.775-6.578-4.599-6.016-45.611-115.814-178.43-242.353-9,970,343-3.867-0.713-67.922